Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Allez M, Mayer L. 2006. Regulatory T cells, peace keepers in the gut. Inflamm Bowel Dis. 10:666–676.
Baecher-Allan C, Hafler DA. 2004. Suppressor T cells in human disease. J Exp Med. 200:273–276.
Baecher-Allan C, Hafler DA. 2006. Human regulatory T cells and their role in autoimmune disease. Immunol Rev. 212:203–216.
Barnett Z, Larussa SH, Hogam M, Wei S, et al. 2004. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64:8451–8455.
Battaglia M, Gregori S, Bacchetta R, Roncarolo MG. 2006. Tr 1 cells: From discovery to their clinical application. Semin Immunol. 18:120–127.
Beissert S, Schwarz A, Schwarz T. 2006. Regulatory T cells. J Invest Dermatol. 126:15–24.
Belkaid Y, Rouse BJ. 2005. Natural regulatory T cells in infectious disease. Nat Immunol. 6: 353–360.
Beyer M, Schultze JL. 2007. CD 4+CD25+high Foxp3+ regulatory T cells in peripheral blood are primarily of effector memory phenotype. J Clin Oncol. 25:2628–2630.
Bluestone JA, Abbas AK. 2003. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 3:253–257.
Bluestone JA. 2004. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci USA. 101:14622–14626.
Brimnes J, Allez M, Dotan I, Mayer L. 2005. Defects in CD8+ regulatory T cells in the Lamina Propria of patients with inflammatory bowel disease. J Immunol. 174:5814–5822.
Buckner JH, Ziegler SF. 2004. Regulating the immune system: The induction f regulatory T cells in periphery. Arthritis Res Ther. 6:215–222.
Cao D, Vollenhoven RV, Klareskog L, Trollmo C, Malstrom V. 2004. CD 25+CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther. 6:R335–346.
Chatenoud L, Salomon B, Bluestone JA. 2001. Suppressor T cells – they’re back and critical for regulation of autoimmunity! Immunol. Rev. 182:149–163.
Chen Z, Benoist C, Mathis D. 2005. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci USA. 102:14735–14740.
Cohen IR, Quintana FJ, Mimran A. 2004. Tregs in T cell vaccination: Exploring the regulation of regulation. J Clin Inv. 114:1227–1232.
Dejaco C, Duftner C, Grubeck-Loebenstein B, Schrimer M. 2006. Imbalance of regulatory T cells in human autoimmune diseases. Immunology. 117:289–300.
Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. 2002. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10 producing, contact-independent type 1-regulatory T cells. J Exp Med. 196:247–253.
Fehervari Z, Sakaguchi S. 2004. CD 4+ Tregs and immune control. J Clin Inv. 114:1209–1217.
Ferretti G, Felici A, Pino MS, Cognetti F. 2006. Does CTLA4 influence the suppressive effects of CD25+CD4+ regulatory T cells? J Clin Oncol. 24:5469–5470.
Fields RC, Bharat A, Mohanakumar T. 2006. The role of regulatory T-cells in transplantation tolerance. ASHI Quarterly. (first quarter):10–15.
Franzece O, Kennedy PTF, Gehring AJ, Gotto GM., et al. 2005. Modulation of the CD8+ T cell response by CD4+CD25+ regulatory T cells in patients with Hepatitis B virus infection. J Virol. 79:3322–3328.
Gershon RK, Kondo K. 1970. Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology. 18:723–737.
Gershon RK. 1975. A disquisition on suppressor T cells. Transplant Rev. 26:170–185.
Godfrey DI, Kronenberg M. 2004. Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Inv. 114:1379–1388.
Gould HJ, Sutton BJ, et al. 2003. The biology of IgE and the basis of the allergic disease. Ann Rev Immunol. 21:579–628.
Green DR, Flood PM, Gershon RK. 1983. Immuno -regulatory T cell pathways. Ann Rev Immunol. 1:439–463.
Groux H. 2003. Type 1 T-regulatory cells: Their role in the control of immune response. Transplantation. 75:85–125.
Hawrylowicz CM, O’Garra A. 2005. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 5:271–283.
Hong J, Zang YC, Nie H, Zhong J. 2006. CD 4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis, PNAS. 103:5024–5029.
Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057–1061.
Ito T, Wang Y-H, Duramad O, Hanabuchi S, et al. 2006. OX 40 ligand shuts down IL-10 producing regulatory T cells. PNAS. 103:13188–13141.
Iwashiro M, Messer RJ, Peterson KE, Stronnes IM, et al. 2001. Immunosuppression of CD4+ regulatory T cells induced by chronic retroviral infection. PNAS. 98:9226–9230.
Janeway Jr. C. 1988. Do suppressor T cells exist? A reply. Scand J Immunol. 27:621–623.
Jerne NK. 1974. Towards a network theory of the immune system. Ann Immunol. 125:373–389.
Joosten SA, Meigjaarden KE, Savage N, Boer TD, et al. 2007. Identification of a human CD8+ regulatory T cells subset that mediates suppression through the chemokine CC chemokine ligand 4. PNAS, 104:8029–8034.
Karlsson MR, Rugtveit J, Brandtzaeg P. 2004. Allergen -responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 12:1679–1688.
Kim JM, Rudensky A. 2006. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev. 212:86–98.
Knoechel B, Lohr J, Kahn E, Bluestone JA, Abbas AK. 2005. Sequential development of interleukin 2-depdent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med. 202:1375–1386.
Kretschmer K, Apostolou I, Jaechel E, Khazaie K., et al. 2006. Making regulatory T cells with defined antigen specificity: Role in autoimmunity and cancer. Immunol Rev. 212:163–169.
Latour RP, Dujardin HC, Mishellany F, Defranoux OB, et al. 2006. Ontogeny , function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. Blood. 108: 2300–2306.
Liu H, Komai-Koma M, Xu D, Liew FY. 2005, Toll-like receptor2 signaling modulates the function of CD4+CD25+ regulatory T cells. PNAS. 103:7048–7053.
Lohr J, Knowchel B, Abbas AK. 2006. Regulatory T cells in periphery. Immunol Rev. 212: 149–162.
Lu L, Wermeck MBF, Cantor H. 2006. The immunoregulatory effects of Qα-1. Immunol Rev. 212:51–59.
Masteller EL, Tang Q, Bluestone JA. 2006. Antigen -specific regulatory T cells-ex vivo expansion and therapeutic potential. Semin Immunol. 18:103–110.
Nishizuka Y, Sakakura T. 1969. Thymus and reproduction: Sex linked dysgenesia of the gonad after neonatal thymectomy in mice. Science. 166:753–755.
O’Garra A, Vieira P. 2004. Regulatory T cells and mechanisms of immune system control. Nat Med. 10:801–805.
O’Garra A, Vieira P, Goldfeld A. 2004. IL -10 producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Inv. 114:1372–1378.
Picca CC, Larkin III J, Boesteanu A, Lerman MA, Rankin AL, Caton AJ. 2006. Role of TCR specificity in CD4+CD25+ regulatory T cell selection. Immunol Rev. 212:74–85.
Qizhi T, Bluestone JA. 2006. Regulatory T cell physiology and application to treat autoimmunity. Immunol Rev. 212:217–237.
Reibke R, Garbi N, Hammerling GH, et al. 2006. CD 8+ regulatory T cells generated by neonatal recognition of peripheral self antigen. PNAS. 103:15142–15147.
Roncarlo MG, Gregori S, Battaglia M, Bacchetta R, et al. 2006. Interleukin -10 secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 212:28–50.
Rouse BT, Sarangi PP, Suvas S. 2006. Regulatory T cells in virus infections. Immunol Rev. 212:272–286.
Sakaguchi S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self tolerance and negative control of immune response. Ann Rev Immunol. 22:531–562.
Sakaguchi S. 2005. Naturally arising Foxp3-expressing Cd25+CD4+ regulatory T cells in immunological tolerance to self and nonself. Nat Immunol. 6:345–352.
Sakaguchi S. 2006. Regulatory T cells: Meden Agan, Immunological reviews, 212:1–5.
Sakaguchi S, Ono M, Setoguchi R, Yagi H, et al. 2006. Foxp 3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 212:8–27.
Sansom DM, Walker LS. 2006. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T cell biology. Immunol Rev. 212:131–148.
Schultze JL. 2006. Regulatory T cells: Timing is everything. Blood. 107:857.
Shevach EM. 2000. Regulatory T cells in autoimmunity. Ann Rev Immunol. 18:423–449.
Shevach EM. 2002. CD 4+CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol. 2:389–400.
Shevack EM. 2004. Fatal attraction: Tumors beckon regulatory T cells. Nat Med. 10:900–901.
Shevach EM, DiPaolo RA, Anderson J, Zhao DM. 2006. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol Rev. 212:60–73.
Snoeck V, Peters I, Cox E. 2006. The IgA system. Vet Res. 37:455–467.
Sutmuller RPM, den Brok HMGM, Kramer M, Bennink EJ, et al. 2006. Toll -like receptors control expansion and function of regulatory T cells. J Clin Invest. 116:485–494.
Taams LS, Palmer DB, Akbar AN, Robinson DS, et al. 2006. Regulatory T cells in human disease and their potential for therapeutic manipulation. Immunology. 118:1–9.
Tarbell KV. Yamazaki S, Steinman RM. 2006. The interaction of dendritic cells with antigen specific, regulatory T cells that suppress autoimmunity. Semin Immunol. 18:93–102.
Thomas D, Zaccone P, Cooke A. 2005. The role of regulatory T cell defects in Type I diabetes and the potential of these cells for therapy. Rev Diabet Stud. 2:9–18.
Umetsu DT, DeKruyff RH. 2006. The regulation of allergy and asthma. Immunol Rev. 212: 238–255.
Vigouroux S, Yvon E, Biagi E, Brenner MK. 2004. Antigen -induced regulatory T cells. Blood. 104:26–33.
Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. 2003. Antigen -dependent proliferation of CD4+CD25+ regulatory T cells in vivo. J Exp Med. 198:249–258.
Walsh PT, Taylor DK, Turka LA. 2004. Tregs and transplantation tolerance. J Clin Inv. 114: 1398–1403.
Walsh PT, Buckler JL, Zhang J, Gelman AE, et al. 2006. PTEN inhibits IL-2 receptor mediated expansion of CD4+CD25+ Tregs. J Clin Inv. 116:2521–2531.
Wan YY, Flavell RA. 2006. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev. 212:114–130.
Wau Y, Flavell RA. 2007. Regulatory T cell functions are subverted and converted owing to attenuated FoxP-3 expression. Nature. 445:766–770.
You S, Thieblemont N, Alayankian MA, Bach J, Chatenoud L. 2006. Transforming growth factor-β and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev. 212:185–202.
Zorn E, Nelson EA, Mohseni M, Porchery F, et al. 2006. IL -2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expression of these cells in vivo. Blood. 108:1571–1579.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Khan, M.M. (2008). Regulatory T Cells and Disease State. In: Immunopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77976-8_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-77976-8_9
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-77975-1
Online ISBN: 978-0-387-77976-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)